Published in Hepatitis Weekly, May 22nd, 1995
Isoniazid and pyrazinamide are well-known hepatotoxic drugs, often used in combination.
"The influence of combined isoniazid and pyrazinamide use on the outcome of patients developing fulminant or subfulminant liver failure is not known," researcher Francois Durand and colleagues wrote ("Deleterious Influence of Pyrazinamide on the Outcome of Patients with Fulminant or Subfulminant Liver Failure during Antituberculous Treatment...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.